Somatostatin in bleeding oesophageal varicesBMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7028.442 (Published 17 February 1996) Cite this as: BMJ 1996;312:442
Important information about trial was omitted
- S A Jenkins,
- I N Baxter
- Non-clinical scientist Reader in surgery University Department of Surgery, Glasgow Royal Infirmary, Glasgow G31 2ER
EDITOR,—We find it hard to understand why, in Peter C Gotzsche and colleagues' double blind placebo controlled trial of somatostatin in acute variceal haemorrhage, patients were not randomised for long periods after the onset of haemorrhage.1 Patients with cirrhosis do not tolerate prolonged periods of bleeding.
The authors elected not to use bolus administration of somatostatin as soon as the continuous infusion was established despite good evidence for this method of administration.2 In 19 randomised controlled trials of somatostatin …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial